Browse classification

Loading Please Wait
A:HUMAN NECESSITIES
 A61: MEDICAL OR VETERINARY SCIENCE; HYGIENE
  A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
   A61L2/00: Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
   A61L2/00P: for pharmaceuticals, biologicals or living parts
   A61L2/00P2: . . using physical methods
   A61L2/00P2A: . . . Filtration
   A61L2/00P2E: . . . Heat
   A61L2/00P2F: . . . Gamma radiation
   A61L2/00P2R: . . . Radiation
   A61L2/00P2R10: . . . . Infrared radiation
   A61L2/00P2R12: . . . . Microwaves
   A61L2/00P2R14: . . . . Particle radiation, e.g. electron-beam, alpha or beta radiation
   A61L2/00P2R16: . . . . using a photocatalyst or photosensitiser
   A61L2/00P2R2: . . . . Gamma radiation
   A61L2/00P2R4: . . . . X-rays
   A61L2/00P2R6: . . . . Ultraviolet radiation
   A61L2/00P2R8: . . . . Visible light
   A61L2/00P4: . . using chemical substances
   A61L2/00P4A: . . . Liquid substances
   A61L2/00P4A2: . . . .  Peroxides
   A61L2/00P4E: . . . Gaseous substances
   A61L2/02: using physical phenomena
   A61L2/025: . . Ultrasonics
   A61L2/02F: . . Filtration
   A61L2/03: . . Electric current
   A61L2/03E: . . . Electrolysis
   A61L2/04: . . Heat
   A61L2/06: . . . Hot gas
   A61L2/07: . . . . Steam
   A61L2/08: . . Radiation
   A61L2/08B: . . . Gamma radiation
   A61L2/08D: . . . X-rays
   A61L2/08F: . . . Visible light
   A61L2/08H: . . . Infrared radiation
   A61L2/08J: . . . Particle radiation, e.g. electron-beam, alpha or beta radiation
   A61L2/08L: . . . using a photocatalyst or photosensitiser
   A61L2/10: . . . Ultra-violet radiation
   A61L2/12: . . . Microwaves
   A61L2/14: . . Plasma, i.e. ionised gases
   A61L2/16: using chemical substances
   A61L2/18: . . Liquid substances or solutions comprising solids or dissolved gases
   A61L2/18L: . . . Ozone dissolved in a liquid
   A61L2/18P: . . . Peroxide solutions
   A61L2/20: . . Gaseous substances, e.g. vapours
   A61L2/20C: . . . Ozone
   A61L2/20D: . . . Formaldehyde
   A61L2/20E: . . . Ethylene oxide
   A61L2/20H: . . . Hydrogen peroxide
   A61L2/22: . . Phase substances, e.g. smokes, aerosols or sprayed or atomised substances
   A61L2/23: . . Solid substances, e.g. granules, powders, blocks, tablets
   A61L2/232: . . . layered or coated
   A61L2/235: . . . cellular, porous or foamed
   A61L2/238: . . . Metals or alloys, e.g. oligodynamic metals
   A61L2/24: Apparatus using programmed or automatic operation
   A61L2/26: Accessories or devices or components used for biocidal treatment
   A61L2/28: . . Devices for testing the effectiveness or completeness of sterilisation, e.g. indicators which change colour
   A61L9/00: Disinfection, sterilisation or deodorisation of air
   A61L9/01: Deodorant compositions compositions released by contact with a liquid A61L9/05
   A61L9/012: . . characterised by being in a special form, e.g. gels, emulsions A61L9/04G takes precedence
   A61L9/013: . . containing animal or plant extracts, or vegetable material
   A61L9/13: by air-liquid contact (e.g. scrubber)
   A61L9/014: . . containing sorbent material, e.g. activated carbon
   A61L9/015: using gaseous or vaporous substances, e.g. ozone
   A61L9/02: . . using substances evaporated in the air by heating or combustion
   A61L9/03: . . . Apparatus therefor
   A61L9/03F: . . . . comprising a fan
   A61L9/03M: . . . . emanating multiple odours
   A61L9/03W: . . . . comprising a wick
   A61L9/04: . . using substances evaporated in the air without heating
   A61L9/04B: . . . with the help of a macromolecular compound as a carrier or diluent A61L9/04G takes precedence
   A61L9/04C: . . . with the help of an organic compound other than a macromolecular compound
   A61L9/04D: . . . with the help of a non-organic compound
   A61L9/04G: . . . air treating gels
   A61L9/05: . . . specially adapted to be released by contact with a liquid, e.g. for toilets
   A61L9/12: . . . Apparatus, e.g. holders, therefor
   A61L9/12F: . . . . comprising a fan
   A61L9/12M: . . . . emanating multiple odours
   A61L9/12W: . . . . comprising a wick
   A61L9/14: using sprayed or atomised substances including air-liquid contact processes
   A61L9/14L: . . air-liquid contact processes, e.g. scrubbing
   A61L9/16: using physical phenomena
   A61L9/18: . . Radiation
   A61L9/20: . . . Ultra-violet radiation
   A61L9/20P: . . . . using a photocatalyst or photosensitiser
   A61L9/22: . . Ionisation
   A61L11/00: Methods specially adapted for refuse desintegrating medical waste B02C19/12M; disposal of medical waste B09B3/00M
   A61L12/00: Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
   A61L12/02: using physical phenomena, e.g. electricity, ultrasonics or ultrafiltration
   A61L12/02E: . . Electrolysis
   A61L12/02F: . . Ultrasounds
   A61L12/04: . . Heat
   A61L12/06: . . Radiation, e.g. ultraviolet or microwaves
   A61L12/06B: . . . Ultraviolet radiation
   A61L12/06D: . . . Microwaves
   A61L12/08: using chemical substances
   A61L12/08B: . . in combination with specific enzymes
   A61L12/08D: . . in a gaseous state
   A61L12/08F: . . Container, accessories or devices therefor
   A61L12/08H: . . Heavy metals
   A61L12/10: . . Halogens or compounds thereof
   A61L12/10B: . . . Chlorine dioxide (ClO2)
   A61L12/10D: . . . Iodine, iodides or iodophores
   A61L12/10F: . . . Hypohalites; Active halogens
   A61L12/12: . . Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone
   A61L12/12B: . . . Ozone
   A61L12/12D: . . . Hydrogen peroxide; Peroxy compounds
   A61L12/12D2: . . . . neutralised with catalase or peroxidase
   A61L12/12D4: . . . . neutralised with catalysts
   A61L12/14: . . Organic compounds not covered by groups A61L12/10 or A61L12/12
   A61L12/14B: . . . Biguanides, e.g. chlorhexidine
   A61L12/14B2: . . . . Polymeric biguanides
   A61L12/14D: . . . Quaternary ammonium compounds
   A61L12/14D2: . . . . Polymeric quaternary ammonium compounds
   A61L12/14F: . . . Aldehydes
   A61L12/14H: . . . Alcohols or derivatives thereof aldehydes A61L12/14F
   A61L12/14K: . . . Mercury containing compounds, e.g. thimerosal
   A61L15/00: Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
   A61L15/07: Stiffening bandages
   A61L15/08: . . containing inorganic materials, e.g. plaster of Paris
   A61L15/10: . . containing organic materials
   A61L15/12: . . containing macromolecular materials
   A61L15/12M: . . . Mixtures of macromolecular compounds
   A61L15/14: . . Use of materials characterised by their function or physical properties
   A61L15/16: Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
   A61L15/18: . . containing inorganic materials
   A61L15/20: . . containing organic materials
   A61L15/22: . . containing macromolecular materials
   A61L15/22M: . . . Mixtures of macromolecular compounds
   A61L15/24: . . . Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof A61L15/22M takes precedence
   A61L15/26: . . . Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof A61L15/22M takes precedence
   A61L15/28: . . . Polysaccharides or their derivatives A61L15/22M takes precedence
   A61L15/30: . . . Rubbers or their derivatives A61L15/22M takes precedence
   A61L15/32: . . . Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin A61L15/22M takes precedence
   A61L15/32A: . . . . Collagen
   A61L15/34: . . . Oils, fats, waxes or natural resins A61L15/22M takes precedence
   A61L15/36: . . containing micro-organisms
   A61L15/38: . . containing enzymes
   A61L15/40: . . containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
   A61L15/42: . . Use of materials characterised by their function or physical properties
   A61L15/42E: . . . Porous materials, e.g. foams or sponges
   A61L15/44: . . . Medicaments
   A61L15/46: . . . Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
   A61L15/48: . . . Surfactants
   A61L15/50: . . . Lubricants; Anti-adhesive agents
   A61L15/52: . . . Water-repellants
   A61L15/54: . . . Radio-opaque materials
   A61L15/56: . . . Wetness-indicators or colourants
   A61L15/58: . . . Adhesives
   A61L15/58M: . . . . Mixtures of macromolecular compounds
   A61L15/60: . . . Liquid-swellable gel-forming materials, e.g. super-absorbents
   A61L15/62: . . . Compostable, hydrosoluble or hydrodegradable materials
   A61L15/64: . . . specially adapted to be resorbable inside the body
   A61L17/00: Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters bone cements or surgical adhesives for soft body tissues A61L24/00; shape or structure of prostheses A61F2/00; shape or structure of catheters A61M5/00
   A61L17/00C: containing a biologically active substance, e.g. a medicament or a biocide
   A61L17/04: Non-resorbable materials
   A61L17/06: At least partially resorbable materials
   A61L17/08: . . of animal origin, e.g. catgut, collagen
   A61L17/10: . . containing macromolecular materials
   A61L17/10B: . . . Polyesters not covered by A61L17/12
   A61L17/12: . . . Homopolymers or copolymers of glycolic acid or lactic acid
   A61L17/14: Post-treatment to improve physical properties
   A61L17/14C: . . Coating
   A61L24/00: Surgical adhesives or cements; Adhesives for colostomy devices
   A61L24/00F: Ingredients of undetermined constitution or reaction products thereof
   A61L24/00H: Use of materials characterised by their function or physical properties
   A61L24/00H2: . . Medicaments; Biocides
   A61L24/00H4: . . Plasticisers
   A61L24/00H6: . . Sprayable compositions
   A61L24/00H7: . . Hydrogels or hydrocolloids
   A61L24/00H8: . . Porous materials, e.g. foams or sponges
   A61L24/00H9: . . Materials resorbable by the body
   A61L24/00R: Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
   A61L24/00R2: . . with an inorganic matrix
   A61L24/00R2A: . . . Carbon
   A61L24/00R2E: . . . Phosphorus containing materials, e.g. apatite
   A61L24/00R2K: . . . Inorganic materials not covered by groups A61L24/00R2A or A61L24/00R2E
   A61L24/00R4: . . with a macromolecular matrix
   A61L24/00R4A: . . . containing fillers of carbon
   A61L24/00R4E: . . . containing fillers of phosphorus-containing inorganic compounds, e.g. apatite
   A61L24/00R4K: . . . containing inorganic fillers not covered by groups A61L24/00R4A or A61L24/00R4E
   A61L24/00R4R: . . . containing macromolecular fillers
   A61L24/02: containing inorganic materials
   A61L24/04: containing macromolecular materials
   A61L24/04M: . . Mixtures of macromolecular materials
   A61L24/04R: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L24/04M takes precedence
   A61L24/06: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds A61L24/04M, A61L24/04Rtake precedence
   A61L24/08: . . Polysaccharides A61L24/04M takes precedence
   A61L24/10: . . Polypeptides; Proteins A61L24/04M takes precedence
   A61L24/10A: . . . Collagen
   A61L24/10E: . . . Gelatin
   A61L24/10F: . . . Fibrin; Fibrinogen
   A61L24/10R: . . . Specific proteins or polypeptides not covered by groups A61L24/10A to A61L24/10F
   A61L24/12: . . Ionomer cements, e.g. glass-ionomer cements A61L24/04M takes precedence
   A61L26/00: Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
   A61L26/00A: containing inorganic materials
   A61L26/00B: containing macromolecular materials
   A61L26/00B2: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds
   A61L26/00B4: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
   A61L26/00B5: . . Polysaccharides
   A61L26/00B6: . . Polypeptides; Proteins; Degradation products thereof
   A61L26/00B6A: . . . Collagen
   A61L26/00B6E: . . . Gelatin
   A61L26/00B6F: . . . Fibrin; Fibrinogen
   A61L26/00B6R: . . . Specific proteins or polypeptides not covered by groups A61L26/00B6A to A61L26/00B6F
   A61L26/00B8: . . Mixtures of macromolecular compounds
   A61L26/00F: Ingredients of undeterminded constitution or reaction products thereof
   A61L26/00H: Use of materials characterised by their function or physical properties
   A61L26/00H2: . . Medicaments; Biocides
   A61L26/00H4: . . Plasticisers
   A61L26/00H6: . . Sprayable compositions
   A61L26/00H7: . . Hydrogels or hydrocolloids
   A61L26/00H8: . . Porous materials, e.g. foams or sponges
   A61L26/00H9: . . Materials resorbable by the body
   A61L26/00R: Composite materials, i.e. containing one material dispersed in amatrix of the same or different material
   A61L27/00: Materials for grafts or prostheses or for coating grafts or prostheses
   A61L27/02: Inorganic materials
   A61L27/02B: . . Other specific inorganic materials not covered by A61L27/04 to A61L27/12
   A61L27/04: . . Metals or alloys
   A61L27/04A: . . . Iron or iron alloys
   A61L27/04F: . . . Cobalt or cobalt alloys
   A61L27/04R: . . . Other specific metals or alloys not covered by A61L27/04A to A61L27/04F or A61L27/06
   A61L27/06: . . . Titanium or titanium alloys
   A61L27/08: . . Carbon; Graphite
   A61L27/10: . . Ceramics or glasses
   A61L27/10A: . . . containing Al2O3
   A61L27/12: . . Phosphorus-containing materials, e.g. apatite
   A61L27/14: Macromolecular materials
   A61L27/16: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds
   A61L27/16B: . . . Rubbers
   A61L27/18: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
   A61L27/20: . . Polysaccharides
   A61L27/22: . . Polypeptides or derivatives thereof, e.g. degradation products
   A61L27/22E: . . . Gelatin
   A61L27/22F: . . . Fibrin; Fibrinogen
   A61L27/22R: . . . Other specific proteins or polypeptides not covered by A61L27/22E, A61L27/22F or A61L27/24
   A61L27/24: . . . Collagen
   A61L27/26: . . Mixtures of macromolecular compounds
   A61L27/28: Materials for coating prostheses
   A61L27/30: . . Inorganic materials
   A61L27/30A: . . . Carbon
   A61L27/30R: . . . Other specific inorganic materials not covered by A61L27/30A to A61L27/32
   A61L27/32: . . . Phosphorus-containing materials, e.g. apatite
   A61L27/34: . . Macromolecular materials
   A61L27/36: containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix isolated natural compounds, e.g. collagen A61L27/24
   A61L27/36B: . . characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
   A61L27/36B10: . . . Vascular tissue, e.g. heart valves
   A61L27/36B12: . . . Intestinal tissue, e.g. small intestinal submucosa
   A61L27/36B14: . . . Extracellular matrix (ECM)
   A61L27/36B2: . . . Bone, e.g. demineralised bone matrix [DBM , bone powder]
   A61L27/36B4: . . . Cartilage, synovial fluid
   A61L27/36B6: . . . Blood, e.g. platelet-rich plasma
   A61L27/36B8: . . . Skin, e.g. dermal papillae
   A61L27/36D: . . characterised by the origin of the biological material other than human or animal , e.g. plant extracts, algae
   A61L27/36F: . . characterised by the site of application in the body materials for artificial blood vessels A61L27/50E; materials for use in artificial skin A61L27/60
   A61L27/36F10: . . . Hollow organs, e.g. bladder, esophagus, urether, uterus, intestine
   A61L27/36F2: . . . Connective tissue
   A61L27/36F2B: . . . . Bones
   A61L27/36F2D: . . . . Cartilage, e.g. meniscus
   A61L27/36F2D2: . . . . . Intervertebral discs mechanical aspects and structures of intervertebral discs A61F2/44D
   A61L27/36F2F: . . . . Ligaments, tendons
   A61L27/36F4: . . . Epithelial tissues other than skin
   A61L27/36F6: . . . Muscle tissue, e.g. sphincter
   A61L27/36F8: . . . Nerve tissue, e.g. brain, spinal cord, nerves, dura mater
   A61L27/36H: . . subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
   A61L27/36H2: . . . characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
   A61L27/36H4: . . . characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
   A61L27/36H6: . . . characterised by the function or physical properties of the final product, where no specific conditions are defined to achieve this A61L27/36H2, A61L27/36H4 take precedence
   A61L27/38: . . containing added animal cells organs or tissue containing native cells A61L27/36
   A61L27/38B: . . . characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
   A61L27/38B10: . . . . Muscle cells, e.g. smooth muscle cells
   A61L27/38B12: . . . . Nerve cells, e.g. dendritic cells, Schwann cells
   A61L27/38B14: . . . . Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
   A61L27/38B2: . . . . Endothelial cells
   A61L27/38B4: . . . . Epithelial cells, e.g. keratinocytes, urothelial cells
   A61L27/38B6: . . . . Cartilage-forming cells, e.g. pre-chondrocytes
   A61L27/38B8: . . . . Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells
   A61L27/38D: . . . characterised by the site of application in the body materials for artificial blood vessels A61L27/50E; materials for use in artificial skin A61L27/60
   A61L27/38D10: . . . . Hollow organs, e.g. bladder, esophagus, urether, uterus
   A61L27/38D2: . . . . Connective tissue
   A61L27/38D2B: . . . . . Bones
   A61L27/38D2D: . . . . . Cartilage, e.g. meniscus
   A61L27/38D2D2: . . . . . . Intervertebral discs mechanical aspects and structures of intervertebral discs A61F2/44D
   A61L27/38D2F: . . . . . Ligaments, tendons
   A61L27/38D2H: . . . . . Dental/periodontal tissues
   A61L27/38D4: . . . . Epithelial tissues other than skin
   A61L27/38D6: . . . . Muscle tissue, e.g. sphincter
   A61L27/38D8: . . . . Nerve tissue, brain, spinal cord, nerves, dura mater
   A61L27/38F: . . . comprising two or more cell types
   A61L27/38F2: . . . . as distinct cell layers
   A61L27/38H: . . . using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
   A61L27/40: Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
   A61L27/42: . . having an inorganic matrix
   A61L27/42A: . . . of carbon
   A61L27/42E: . . . of phosphorus containing material, e.g. apatite
   A61L27/42R: . . . of other specific inorganic materials not covered by A61L27/42A or A61L27/42E
   A61L27/44: . . having a macromolecular matrix
   A61L27/44A: . . . with carbon fillers
   A61L27/44R: . . . with other specific inorganic fillers other than those covered by A61L27/44A or A61L27/46
   A61L27/46: . . . with phosphorus-containing inorganic fillers
   A61L27/48: . . . with macromolecular fillers
   A61L27/50: Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
   A61L27/50B: . . Plasticizers
   A61L27/50D: . . Stabilizers
   A61L27/50E: . . for artificial blood vessels apparatus for applying cells on a blood vessel prosthesis A61F2/06B
   A61L27/52: . . Hydrogels or hydrocolloids
   A61L27/54: . . Biologically active materials, e.g. therapeutic substances
   A61L27/56: . . Porous materials, e.g. foams or sponges
   A61L27/58: . . Materials at least partially resorbable by the body
   A61L27/60: . . Materials for use in artificial skin
   A61L28/00: Materials for colostomy devices
   A61L28/00A: containing inorganic materials
   A61L28/00B: containing macromolecular materials
   A61L28/00B2: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds
   A61L28/00B4: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
   A61L28/00B5: . . Polysaccharides
   A61L28/00B6: . . Polypeptides; Proteins; Degradation products thereof
   A61L28/00B8: . . Mixtures of macromolecular compounds
   A61L28/00F: Ingredients of undeterminded constitution or reaction products thereof
   A61L28/00H: Use of materials characterised by their function or physical properties
   A61L28/00H2: . . Medicaments; Biocides
   A61L28/00H4: . . Plasticisers
   A61L28/00H6: . . Sprayable compositions
   A61L28/00H7: . . Hydrogels or hydrocolloids
   A61L28/00H8: . . Porous materials, e.g. foams or sponges
   A61L28/00H9: . . Materials resorbable by the body
   A61L28/00K: Materials for coating
   A61L28/00K2: . . Inorganic materials
   A61L28/00K4: . . Macromolecular materials
   A61L28/00R: Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
   A61L28/00R2: . . with an inorganic matrix
   A61L28/00R4: . . with a macromolecular matrix
   A61L28/00R4A: . . . containing fillers of carbon
   A61L28/00R4E: . . . containing fillers of phosphorus-containing inorganic compounds
   A61L28/00R4K: . . . containing inorganic fillers not covered by groups A61L28/00R4A or A61L28/00R4E
   A61L28/00R4R: . . . containing macromolecular fillers
   A61L29/00: Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
   A61L29/00F: Ingredients of undetermined constitution or reaction products thereof
   A61L29/02: Inorganic materials
   A61L29/04: Macromolecular materials
   A61L29/04B: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds
   A61L29/04B2: . . . Rubbers
   A61L29/04D: . . Polysaccharides
   A61L29/04F: . . Proteins; Polypeptides; Degradation products thereof
   A61L29/04F10: . . . Other specific proteins or polypeptides not covered by A61L29/04F2 to A61L29/04F6
   A61L29/04F2: . . . Collagen
   A61L29/04F4: . . . Gelatin
   A61L29/04F6: . . . Fibrin; Fibrinogen
   A61L29/04M: . . Mixtures of macromolecular compounds
   A61L29/06: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
   A61L29/08: Materials for coatings
   A61L29/08B: . . Macromolecular materials
   A61L29/10: . . Inorganic materials
   A61L29/10A: . . . Carbon
   A61L29/10R: . . . Inorganic materials other than carbon
   A61L29/12: Composite materials, i.e. containig one material dispersed in a matrix of the same or different material
   A61L29/12B: . . having an inorganic matrix
   A61L29/12D: . . having a macromolecular matrix
   A61L29/14: Materials characterised by their function or physical properties, e.g. lubricating compositions
   A61L29/14B: . . Plasticizers
   A61L29/14D: . . Stabilizers
   A61L29/14F: . . Hydrogels or hydrocolloids
   A61L29/14H: . . Porous materials, e.g. foams or sponges
   A61L29/14K: . . Materials at least partially resorbable by the body
   A61L29/16: . . Biologically active materials, e.g. therapeutic substances
   A61L29/18: . . Materials at least partially X-ray or laser opaque
   A61L31/00: Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices shape or structure of stent-grafts A61F2/07, of stents A61F2/82, of surgical gloves A61B19/04, of surgical drapes A61B19/08, of occluding devices A61B17/12P
   A61L31/00F: Ingredients of undetermined constitution or reaction products thereof
   A61L31/02: Inorganic materials
   A61L31/02B: . . Metals or alloys
   A61L31/02D: . . Carbon; Graphite
   A61L31/02F: . . Ceramic or ceramic-like structures, e.g. glasses
   A61L31/02R: . . Other inorganic materials not covered by A61L31/02B to A61L31/02F
   A61L31/04: Macromolecular materials
   A61L31/04B: . . Mixtures of macromolecular compounds
   A61L31/04D: . . Polysaccharides
   A61L31/04F: . . Proteins; Polypeptides; Degradation products thereof
   A61L31/04F10: . . . Other specific proteins or polypeptides not covered by A61L31/04F2 to A61L31/04F6
   A61L31/04F2: . . . Collagen
   A61L31/04F4: . . . Gelatin
   A61L31/04F6: . . . Fibrin; Fibrinogen
   A61L31/04H: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds A61L31/04B takes precedence
   A61L31/04H3: . . . Rubbers
   A61L31/06: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L31/04B takes precedence
   A61L31/08: Materials for coatings
   A61L31/08B: . . Inorganic materials
   A61L31/08B2: . . . Carbon; Graphite
   A61L31/08B4: . . . Phosphorus-containing materials, e.g. apatite
   A61L31/08B6: . . . Other specific inorganic materials not covered by A61L31/08B2 or A61L31/08B4
   A61L31/10: . . Macromolecular material
   A61L31/12: Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
   A61L31/12B: . . having an inorganic matrix
   A61L31/12B2: . . . of carbon
   A61L31/12B4: . . . of phosphorus-containing materials , e.g. apatite
   A61L31/12B6: . . . of other specific inorganic materials not coverd by A61L31/12B2 or A61L31/12B4
   A61L31/12D: . . having a macromolecular matrix
   A61L31/12D10: . . . containing macromolecular fillers
   A61L31/12D2: . . . containing carbon fillers
   A61L31/12D4: . . . containing fillers of phosphorus-containing inorganic materials
   A61L31/12D6: . . . containing other specific inorganic fillers not covered by A61L31/12D2 or A61L31/12D4
   A61L31/14: Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
   A61L31/14B: . . Plasticizers
   A61L31/14D: . . Stabilizers
   A61L31/14F: . . Hydrogels or hydrocolloids
   A61L31/14H: . . Porous materials, e.g. foams or sponges
   A61L31/14K: . . Materials at least partially resorbable by the body
   A61L31/16: . . Biologically active materials, e.g. therapeutic substances A61L31/04F10 takes precedence
   A61L31/18: . . Materials at least partially X-ray or laser opaque
   A61L33/00: Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
   A61L33/00H: Use of materials characterised by their function or physical properties
   A61L33/00H2: . . Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
   A61L33/00H2A: . . . using a surface active agent
   A61L33/00H2E: . . . using a quaternized group or a protonated amine group of the substrate
   A61L33/00H2F: . . . using an intermediate layer of polymer
   A61L33/00H2K: . . . using a polymer with positively charged atoms in the polymeric backbone, e.g. ionenes
   A61L33/00H2T: . . . characterised by the choice of an antithrombatic agent other than heparin heparino´d A61L33/08; polypeptides A61L33/12
   A61L33/00H3: . . Enzymes, e.g. urokinase, streptokinase
   A61L33/00H4: . . Plasticizers
   A61L33/00H5: . . Stabilizers
   A61L33/00H7: . . Hydrogels or hydrocolloids
   A61L33/00H8: . . Porous materials, e.g. foams or sponges
   A61L33/00R: Chemical modification of the substrate
   A61L33/00R2: . . by reacting with an organic compound other than heparin
   A61L33/00R4: . . by grafting of a monomer onto the substrate
   A61L33/00T: Physical treatment, e.g. plasma treatment
   A61L33/02: Use of inorganic materials
   A61L33/02B: . . Metal or alloys
   A61L33/02D: . . [N:Carbon; Graphite]
   A61L33/02R: . . Other specific inorganic materials not covered by A61L33/02B or A61L33/02D
   A61L33/04: Use of organic materials, e.g. acetylsalicyclic acid
   A61L33/06: Use of macromolecular materials
   A61L33/06A: . . Mixtures of macromolecular compounds
   A61L33/06B: . . obtained by reactions only involving carbon-to-carbon unsaturated bonds A61L33/06A takes precedence
   A61L33/06B2: . . . Rubbers
   A61L33/06D: . . obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds A61L33/06A takes precedence
   A61L33/08: . . Polysaccharides
   A61L33/12: . . Polypeptides, proteins or derivatives thereof, e.g. degradation products thereof
   A61L33/12A: . . . Collagen
   A61L33/12E: . . . Gelatin
   A61L33/12F: . . . Fibrin
   A61L33/12R: . . . Other specific proteins or polypeptides not covered by A61L33/12A to A61L33/12F
   A61L33/18: Use of ingredients of undetermined constitution or reaction products thereof